Key points are not available for this paper at this time.
Design
Review
Reinforces cardiometabolic syndrome as high-risk cluster; leaves open targeted intervention trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: